BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8774851)

  • 1. Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment.
    Chagas JR; Ferrer-Di Martino M; Gauthier F; Lalmanach G
    FEBS Lett; 1996 Sep; 392(3):233-6. PubMed ID: 8774851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
    Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
    Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity.
    Chen Y; Plouffe C; Ménard R; Storer AC
    FEBS Lett; 1996 Sep; 393(1):24-6. PubMed ID: 8804416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An NMR-based identification of peptide fragments mimicking the interactions of the cathepsin B propeptide.
    Yu Y; Vranken W; Goudreau N; de Miguel E; Magny MC; Mort JS; Dupras R; Storer AC; Ni F
    FEBS Lett; 1998 Jun; 429(1):9-16. PubMed ID: 9657374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent slow-binding inhibition of cathepsin B by its propeptide.
    Fox T; de Miguel E; Mort JS; Storer AC
    Biochemistry; 1992 Dec; 31(50):12571-6. PubMed ID: 1472493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide.
    Turk D; Podobnik M; Kuhelj R; Dolinar M; Turk V
    FEBS Lett; 1996 Apr; 384(3):211-4. PubMed ID: 8617355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion.
    Cygler M; Sivaraman J; Grochulski P; Coulombe R; Storer AC; Mort JS
    Structure; 1996 Apr; 4(4):405-16. PubMed ID: 8740363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
    Schaschke N; Deluca D; Assfalg-Machleidt I; Höhneke C; Sommerhoff CP; Machleidt W
    Biol Chem; 2002 May; 383(5):849-52. PubMed ID: 12108551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
    Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
    J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself.
    Mach L; Schwihla H; Stüwe K; Rowan AD; Mort JS; Glössl J
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):437-42. PubMed ID: 8393661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core.
    Mása M; Maresová L; Vondrásek J; Horn M; Jezek J; Mares M
    Biochemistry; 2006 Dec; 45(51):15474-82. PubMed ID: 17176069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of trypanosomal cysteine proteinases by their propeptides.
    Lalmanach G; Lecaille F; Chagas JR; Authié E; Scharfstein J; Juliano MA; Gauthier F
    J Biol Chem; 1998 Sep; 273(39):25112-6. PubMed ID: 9737969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of cathepsin S by its propeptide--specificity and mechanism of action.
    Maubach G; Schilling K; Rommerskirch W; Wenz I; Schultz JE; Weber E; Wiederanders B
    Eur J Biochem; 1997 Dec; 250(3):745-50. PubMed ID: 9461297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysis by cathepsin B of fluorescent peptides derived from human prorenin.
    Almeida PC; Oliveira V; Chagas JR; Meldal M; Juliano MA; Juliano L
    Hypertension; 2000 Jun; 35(6):1278-83. PubMed ID: 10856277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-proteinase-inhibiting function of T kininogen and of its proteolytic fragments.
    Moreau T; Esnard F; Gutman N; Degand P; Gauthier F
    Eur J Biochem; 1988 Apr; 173(1):185-90. PubMed ID: 3356189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
    Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
    Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.
    Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F
    Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
    Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.